Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Number of holders
-
807
-
Total shares
-
39M
-
Shares change
-
-531K
-
Total reported value, excl. options
-
$4.56B
-
Value change
-
-$62.5M
-
Put/Call ratio
-
2.68
-
Number of buys
-
275
-
Number of sells
-
-360
-
Price
-
$116.96
Significant Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q3 2022
839 filings reported holding IBB - ISHARES TR - ISHARES BIOTECH as of Q3 2022.
ISHARES TR - ISHARES BIOTECH (IBB) has 807 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39M shares
.
Largest 10 shareholders include BANK OF AMERICA CORP /DE/ (10.1M shares), MORGAN STANLEY (3.71M shares), ROYAL BANK OF CANADA (1.71M shares), CITIGROUP INC (1.57M shares), UBS Group AG (1.54M shares), GOLDMAN SACHS GROUP INC (1.31M shares), JANE STREET GROUP, LLC (952K shares), WELLS FARGO & COMPANY/MN (811K shares), BNP PARIBAS ARBITRAGE, SNC (726K shares), and COMMERCE BANK (689K shares).
This table shows the top 807 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.